Ron Balczon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ron Balczon has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alison Killilea
The University of South Alabama, Mobile 2 Department of Cell Biology and Neuroscience AL 36688, USA
1 shared publicationC. Simerly
Pittsburgh Developmental Center of Magee‐Women's Research Institute and Departments of Obstetrics‐Gynecology‐Reproductive Sciences and Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
1 shared publicationD. Takahashi
Pittsburgh Developmental Center of Magee‐Women's Research Institute and Departments of Obstetrics‐Gynecology‐Reproductive Sciences and Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania
1 shared publicationDarcy Hansen
The University of South Alabama, Mobile 2 Department of Cell Biology and Neuroscience AL 36688, USA
1 shared publication- Gerald Schatten
Pittsburgh Development Center
1 shared publication Harish C. Joshi
Department of Anatomy and Cell Biology 1 , Emory University School of Medicine, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- 1 August 2003
- Published by Springer Nature in Chromosoma
- Vol. 112 (2) , 96-102
Analysis of detached human kinetochores
- 1 August 2003
- Published by Springer Nature in Chromosoma
- Vol. 112 (2) , 96-102
Analysis of detached human kinetochores
- 19 June 2002
- Published by Wiley in Cell Motility
- Vol. 52 (3) , 183-192
Arrest of cell cycle progression during first interphase in murine zygotes microinjected with anti‐PCM‐1 antibodies
To investigate the function of the centrosome protein PCM‐1, antibodies against PCM‐1 were microinjected into either germinal vesicle stage meiotic oocytes or fertilized mouse eggs, and cell cycle progression events (i.e., microtubule assembly, chromosome and centrosome organization, meiotic maturation) were assayed. These studies determined that microinjected PCM‐1 antibodies arrested cell cycle progression, with anti‐PCM‐1 arresting fertilized eggs at the pronucleate stage when injected during G1. Analysis of the injected eggs determined that centrosome disruption and microtubule cytaster disorganization accompanied the cell cycle arrest. Anti‐PCM‐1 blocked neither pronuclear centration, completion of mitosis when microinjected into zygotes at G2, nor meiotic maturation when microinjected into immature oocytes. These results identify a novel role for PCM‐ 1 in cell cycle regulation, and indicate that PCM‐1 must fulfill an essential function for cells to complete interphase. Cell Motil. Cytoskeleton 52:183–192, 2002.
- 19 June 2002
- Published by Wiley in Cell Motility
- Vol. 52 (3) , 183-192
Arrest of cell cycle progression during first interphase in murine zygotes microinjected with anti‐PCM‐1 antibodies
To investigate the function of the centrosome protein PCM‐1, antibodies against PCM‐1 were microinjected into either germinal vesicle stage meiotic oocytes or fertilized mouse eggs, and cell cycle progression events (i.e., microtubule assembly, chromosome and centrosome organization, meiotic maturation) were assayed. These studies determined that microinjected PCM‐1 antibodies arrested cell cycle progression, with anti‐PCM‐1 arresting fertilized eggs at the pronucleate stage when injected during G1. Analysis of the injected eggs determined that centrosome disruption and microtubule cytaster disorganization accompanied the cell cycle arrest. Anti‐PCM‐1 blocked neither pronuclear centration, completion of mitosis when microinjected into zygotes at G2, nor meiotic maturation when microinjected into immature oocytes. These results identify a novel role for PCM‐ 1 in cell cycle regulation, and indicate that PCM‐1 must fulfill an essential function for cells to complete interphase. Cell Motil. Cytoskeleton 52:183–192, 2002.
- 1 November 2001
- Published by Springer Nature in Chromosoma
- Vol. 110 (6) , 381-392
Overexpression of cyclin A in human HeLa cells induces detachment of kinetochores and spindle pole/centrosome overproduction
The combination of hydroxyurea (HU) and caffeine has been used for inducing kinetochore dissociation from mitotic chromosomes and for causing centrosome/spindle pole amplification. However, these effects on microtubule organizing centers (MTOCs) are limited to certain cell types. It was reasoned that if the biochemical differences in MTOC behavior between cells following HU treatment could be identified, then critical information concerning the regulation of these organelles would be obtained. During these studies, it was determined that cells from hamster, rat, and deer could be induced to enter mitosis with dissociated kinetochores and to synthesize centrosomes during arrest with HU, while cells from human and mouse could not. Comparisons between human HeLa cells and CHO cells determined that cyclin A levels were depressed in HeLa cells relative to CHO cells following HU addition. Overexpression of cyclin A in HeLa cells converted them to a cell type capable of detaching kinetochores from mitotic chromosomes. Ultrastructural analyses determined that the detached human kinetochores exhibited a normal plate-like morphology and appeared capable of associating with microtubules. In addition, HeLa cells overexpressing cyclin A also overproduced spindle poles during HU arrest, demonstrating that cyclin A activity also is important for centrosome replication during interphase. In summary, elevated cyclin A levels are important for the capacity of cells to be driven into mitosis by caffeine addition, for the ability of cells to progress to mitosis with detached kinetochores, and for centrosome/spindle pole replication.
- 1 November 2001
- Published by Springer Nature in Chromosoma
- Vol. 110 (6) , 381-392
Overexpression of cyclin A in human HeLa cells induces detachment of kinetochores and spindle pole/centrosome overproduction
The combination of hydroxyurea (HU) and caffeine has been used for inducing kinetochore dissociation from mitotic chromosomes and for causing centrosome/spindle pole amplification. However, these effects on microtubule organizing centers (MTOCs) are limited to certain cell types. It was reasoned that if the biochemical differences in MTOC behavior between cells following HU treatment could be identified, then critical information concerning the regulation of these organelles would be obtained. During these studies, it was determined that cells from hamster, rat, and deer could be induced to enter mitosis with dissociated kinetochores and to synthesize centrosomes during arrest with HU, while cells from human and mouse could not. Comparisons between human HeLa cells and CHO cells determined that cyclin A levels were depressed in HeLa cells relative to CHO cells following HU addition. Overexpression of cyclin A in HeLa cells converted them to a cell type capable of detaching kinetochores from mitotic chromosomes. Ultrastructural analyses determined that the detached human kinetochores exhibited a normal plate-like morphology and appeared capable of associating with microtubules. In addition, HeLa cells overexpressing cyclin A also overproduced spindle poles during HU arrest, demonstrating that cyclin A activity also is important for centrosome replication during interphase. In summary, elevated cyclin A levels are important for the capacity of cells to be driven into mitosis by caffeine addition, for the ability of cells to progress to mitosis with detached kinetochores, and for centrosome/spindle pole replication.
- Open Access
- 15 February 2001
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 114 (4) , 797-809
Kendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1
The centrosome is responsible for nucleating microtubules and performing other cellular roles. To define the organization of the centrosome more completely, a human anti-centrosome serum was used to screen a human cDNA library, and a cDNA encoding a >350 kDa centrosome protein was identified. Sequence analyses revealed that this novel centrosome protein contains two coiled-coil domains bounded by non-coiled regions. The N-terminal region of the protein, named pericentrin-B, shares 61% identity (75% similarity) with pericentrin, suggesting an evolutionary relationship between these proteins. Antibodies against pericentrin-B stain centrosomes at all stages of the cell cycle, and pericentrin-B remains associated with centrosomes following microtubule depolymerization. Immunodepletion of neither pericentrin-B nor PCM-1 from cellular extracts inhibited the ability of salt-stripped centrosomes to recover microtubule nucleation potential, demonstrating that neither protein plays a key role in microtubule nucleation processes. Moreover, the binding of both PCM-1 and pericentrin-B with salt-stripped centrosomes required intact microtubules, demonstrating that the association of PCM-1 and pericentrin-B with centrosomes is a late event in the centrosome maturation process. Finally, pericentrin-B and PCM-1 coimmunoprecipitate, suggesting that PCM-1 and pericentrin-B form a functional complex in cells. This observation may help to explain the generation of anti-centrosome autoantibodies in certain autoimmune patients and may be important for centrosome function.
- 15 February 2001
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 114 (4) , 797-809
Open AccessKendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1
The centrosome is responsible for nucleating microtubules and performing other cellular roles. To define the organization of the centrosome more completely, a human anti-centrosome serum was used to screen a human cDNA library, and a cDNA encoding a >350 kDa centrosome protein was identified. Sequence analyses revealed that this novel centrosome protein contains two coiled-coil domains bounded by non-coiled regions. The N-terminal region of the protein, named pericentrin-B, shares 61% identity (75% similarity) with pericentrin, suggesting an evolutionary relationship between these proteins. Antibodies against pericentrin-B stain centrosomes at all stages of the cell cycle, and pericentrin-B remains associated with centrosomes following microtubule depolymerization. Immunodepletion of neither pericentrin-B nor PCM-1 from cellular extracts inhibited the ability of salt-stripped centrosomes to recover microtubule nucleation potential, demonstrating that neither protein plays a key role in microtubule nucleation processes. Moreover, the binding of both PCM-1 and pericentrin-B with salt-stripped centrosomes required intact microtubules, demonstrating that the association of PCM-1 and pericentrin-B with centrosomes is a late event in the centrosome maturation process. Finally, pericentrin-B and PCM-1 coimmunoprecipitate, suggesting that PCM-1 and pericentrin-B form a functional complex in cells. This observation may help to explain the generation of anti-centrosome autoantibodies in certain autoimmune patients and may be important for centrosome function.